Navigation Links
Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds
Date:3/25/2008

WORCESTER, Mass. March 25, 2008 -- Exposure to levels of radon gas typically found in 90 percent of American homes appears to reduce the risk of developing lung cancer by as much as 60 percent, according to a study published in the March 2008 issue of the journal Health Physics. The finding differs significantly from the results of previous case-control studies of the effects of low-level radon exposure, which have detected a slightly elevated lung cancer risk (but without statistical significance) or no risk at all.

The study, undertaken jointly by researchers at Worcester Polytechnic Institute (WPI), Fallon Clinic, and Fallon Community Health Plan, is the first to observe a statistically significant hormetic effect of low-level radon exposure. Toxins and other environmental stressors (including radiation) that have a beneficial effect at very low doses are said to exhibit hormesis (scientists believe that the low doses of toxins may stimulate repair mechanisms in cells). Home exposure to radon, a naturally occurring radioactive decay product of radium, has been thought to be the second leading cause of lung cancer, after cigarette smoking. Chemically inert, it can percolate out of the ground into basements.

The study was initiated and managed by Donald F. Nelson, now professor emeritus of physics at WPI, during the 1990s, a time when concern over the link between residential radon exposure and lung cancer was growing. Nelson says the aim was to try to establish what level of radon exposure actually correlated with significant lung cancer risk and to establish a safety zone for home radon levels. We were certainly not looking for a hormetic effect, says co-author Joel H. Popkin of Fallon Clinic and St. Vincent Hospital in Worcester. Indeed, we were stunned when the data pointed to that conclusion in such a strong way.

In the study, the exposure of 200 individuals with confirmed cases of primary lung cancer to radon was compared to t
'/>"/>

Contact: Michael Dorsey
mwdorsey@wpi.edu
508-831-5609
Worcester Polytechnic Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Low exposure to asbestos-like mineral from Montana vermiculite may up lung disease risk
2. Moderate prenatal exposure to alcohol and stress in monkeys can cause touch sensitivity
3. MIT: Prenatal arsenic exposure detected in newborns
4. Time spent in car drives up air pollution exposure
5. Nanoparticle exposures happen, says expert
6. Researchers developing device to predict proper light exposure for human health
7. UCR engineers to develop new tool to measure how environmental exposures affect health
8. Meth exposure in young adults leads to long-term behavioral consequences
9. High levels of estrogen associated with breast cancer recurrence
10. Increased allergen levels in homes linked to asthma
11. New genetic variants associated with lipid levels, risk for coronary artery disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... biological clock may have just gotten a little lo...a report that the number of genes under control of...ago. The biological clock in a much-studied model ...ported. The new study implies that the clock may b...elp to explain why the clock is so far-reaching in...
(Date:8/28/2008)...on from the atomic bomb blasts in Hiroshima and Na...mes in some survivors who later developed papillar...researchers. , In the September 1, 2008, issue o...ociation for Cancer Research, the scientists repor..., were comparably young at the time, and developed...
(Date:8/28/2008)...e discovery of the first new living species of gia...e published online on August 28th in Current Biol...nce reveals that the new species, called Tridacna... of giant clams in the Red Sea, it now represents ... , The researchers said they cannot say for sure...
(Date:8/28/2008)...le lizards begin and end the day with displays of ...nsions of a colorful neck flap, or dewlap -- to de... "Anoles are highly visual species, so in that se...l displays to mark territory," said Terry J. Ord, ...rd University,s Museum of Comparative Zoology. The...
Breaking Biology News(10 mins):Study shows more genes are controlled by biological clocks 2Study shows more genes are controlled by biological clocks 3Researchers discover atomic bomb effect results in adult-onset thyroid cancer 2New giant clam species offers window into human past 2Feats of strength begin a lizard's day 2BioMS Medical to Present at Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 5069 1BioMS Medical to Present at Acumen BioFin Rodman 26 Renshaw 9th Annual Healthcare Conference 5069 2HearAtLast Teams Up with American Express and Wal Mart to Conquer Hearing Loss 5067 1HearAtLast Teams Up with American Express and Wal Mart to Conquer Hearing Loss 5067 2HearAtLast Teams Up with American Express and Wal Mart to Conquer Hearing Loss 5067 3HearAtLast Teams Up with American Express and Wal Mart to Conquer Hearing Loss 5067 4XTL Announces Delisting From the Official List of the United Kingdom Listing Authority 5065 1XTL Announces Delisting From the Official List of the United Kingdom Listing Authority 5065 2XTL Announces Delisting From the Official List of the United Kingdom Listing Authority 5065 3King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 1King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 3King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 4King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 5King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 6
...he United States and other northern mid- and upper...fsetting global warming than previously thought, a.... The study, which sheds light on the so-called mi...forests are removing an unexpectedly high proporti...y offsetting carbon entering the air through indus...
...t has again vetoed the Stem Cell Research Enhancem...bryonic stem cell research. AAAS, the world’s larg...d coalition of Americans spanning all parties and ...onsensus is that embryonic stem cell research is a...effective treatments for devastating conditions li...
...th the oral antiviral Tamiflu (oseltamivir) and pr...could be one of the most cost-effective strategies...a pandemic. According to modelling research presen..., a stockpile of Tamiflu sufficient to cover 65% o...ximately half. This study was announced at the lea...
...ting our feelings into words — talking with a ther... feel better" A new brain imaging study by UCLA ps...akes our sadness, anger and pain less intense. , ...e of the same members of the research team, combin...ings to provide the first neural evidence for why ...
Other Biology News:Scientists close in on missing carbon sink 2Scientists close in on missing carbon sink 3AAAS decries latest stem cell veto 2AAAS decries latest stem cell veto 3Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention 2Putting feelings into words produces therapeutic effects in the brain 2Putting feelings into words produces therapeutic effects in the brain 3Putting feelings into words produces therapeutic effects in the brain 4Putting feelings into words produces therapeutic effects in the brain 5
(Date:8/28/2008).... 28 /- Truman Medical Centers (TMC),...ates to install the,Siemens SOMATOM Definition AS ...canner is a highly adaptive scanner, providing exc...sure to the patient., "To be one of the first med..., first of its kind, state-of-the-art technology c...
(Date:8/28/2008)...28 /- Barr Pharmaceuticals,...diary, Barr Laboratories,Inc., received final app...A) to manufacture and market a generic version of ...drobromide), 4 mg, 8 mg and 12 mg tablets. Barr,in...ct immediately., Barr filed an Abbreviated New Dr...
(Date:8/28/2008)...st 28 /- ThromboGenics NV,(...ocused on innovative,treatments for eye disease, v...iness update and its financial results for the six...irst half of 2008, ThromboGenics has achieved a nu...ompany to successfully pursue the,next stage of it...
(Date:8/28/2008)... CoreValve ( www.corevalve.com ) announced today t...uation of its proprietary percutaneous ReValving S...mounted in a self-expanding frame, was initiated l...f. (Business Wire EON) August 28, 2008 -- The fir...ystem were performed in two days by John Ormiston,...
Breaking Biology Technology:Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the World's First Adaptive 128-slice CT Scanner 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5ThromboGenics Announces Half Year Results 2008 2ThromboGenics Announces Half Year Results 2008 3ThromboGenics Announces Half Year Results 2008 4ThromboGenics Announces Half Year Results 2008 5 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries 2
... FLEXSTATION IS A FLEXIBLE TOOL FOR ASSAY DEVELOP...PERIMENTAL SET-UP , EASY DATA ANALYSIS , ...TATION OR FLIPR , , Introduction ...nduces the flow of calcium ions out of intracellul...ascade. Cell signaling through calcium mobilizatio...
...N FOR DIVERSIFIED TARGETS, , , , ,...NADHERENT CELL TYPES , , HIGHER SIGNAL I... , COMPATIBLE WITH MORE TARGETS , , ...mobilization assays for screening GPCR targets are...ey generate high quality leads. Molecular Devices ...
....D. and Michael Su, M.S., , Molec...UCTION , Immunoassays have traditionally em...dilutions of samples were necessary to ensure that...Recently, chemiluminescent immunoassays, with grea...ecome commercially available 1 . The QuantiGlo TNF...
...nc., 6519 Dumbarton Circle, Fremont, CA 94555. ,...mediated gene expression knockdown studies is the ...e Reagent System and the Molecular Devices LMax II...IL-8 mRNA in PMA-induced HeLa cells, following siR...down discerned differences of less than 10% in mRN...
Other Biology Technology:Gq-coupled receptor assays: a comparison of FLEXstation and FLIPR 2Gq-coupled receptor assays: a comparison of FLEXstation and FLIPR 3FLIPR Calcium 3 Assay Kit Datasheet 2FLIPR Calcium 3 Assay Kit Datasheet 3High Sensitivity, Wide Dynamic Range, Horseradish Peroxidase (HRP) ELISA Using the LMax Microplate Luminometer (MaxLine Application Note #41) 2High Sensitivity, Wide Dynamic Range, Horseradish Peroxidase (HRP) ELISA Using the LMax Microplate Luminometer (MaxLine Application Note #41) 3Measuring siRNA-mediated knockdown of IL-8 mRNA 2Measuring siRNA-mediated knockdown of IL-8 mRNA 3Measuring siRNA-mediated knockdown of IL-8 mRNA 4
... 3000 power supply, 220-240 V, is used for protein...ectric focusing (IEF). The system includes both th...ers, chassis, harvesting apparatus, cooling finger...10 ml Bio-Lyte ampholytes (pH 3-10), 60 ml syringe...
...s used for protein separation and purification by ...m includes both the mini (18 ml) and standard (60 ...us, cooling finger, electrode chambers, 10 ml Bio-...protein sample, 2 vent buttons, and one each of th...
SIGNETs BCIP/NBT Chromogen system consists of [5-Bromo-4-Chloro-3-,Indolyl Phosphate/Nitro Blue Tetrazolium] chromogen in a single component,solution. The ready-to-use BCIP/NBT solution reacts in
Mouse monoclonal antibody raised against a partial recombinant VEGFB. NCBI Entrez Gene ID = VEGFB
Biology Products: